BioCentury
ARTICLE | Clinical News

Glythera preclinical data

November 3, 2014 8:00 AM UTC

In a mouse xenograft model of cancer, an antibody-drug conjugate (ADC) containing Glythera's PermaLink linker led to increased anticancer activity vs. an ADC containing a maleimide-based linker. Data ...